{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-083396","form_type":"8-K","ticker":"OSTX","cik":"0001795091","company_name":"OS Therapies Inc","filed_at":"2025-09-02T23:59:59+00:00","discovered_at":"2026-05-14T18:02:45.016720+00:00","generated_at":"2026-05-17T08:55:49.054185+00:00","sec_items":["1.01","3.02","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"OS Therapies completes warrant inducement, raises $3.8M; extends funding into 2027","bullets":["Raised ~$3.78M gross from exercise of 3,373,043 existing warrants at $1.12; issued new warrants at $3.00 exercise price.","New warrants have forced exercise provision if stock trades above $9.00 for 20 consecutive days; could provide over $20M.","Proceeds to accelerate OST-HER2 commercial launch for pulmonary metastatic osteosarcoma; company funded into 2027.","Removal of old $1.12 warrants reduces potential short selling activity, per CEO Paul Romness.","Offering completed with all remaining holders; substantially similar to prior inducement offers in June/July 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-083396","json":"https://secwatch.observer/filing/0001213900-25-083396.json","markdown":"https://secwatch.observer/filing/0001213900-25-083396.md","text":"https://secwatch.observer/filing/0001213900-25-083396.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1795091/000121390025083396/0001213900-25-083396-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1795091/000121390025083396/ea0255568-8k_ostherap.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T08:55:49.054185+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}